Albireo Pharma, Inc. Gains 44.76%

Albireo Pharma, Inc. (ALBO:NASDAQ) rocketted at $39.62, a gain of 44.8%. On Fri 04 Sep 20, ALBO:NASDAQ hit a New 2-Week Intraday Low of $26.04. The stock got featured on our News Catalysts scanner on Tue 08 Sep 20 at 04:34 PM in the 'PUBLIC OFFERING' category. From Fri 21 Aug 20, the stock recorded 40.00% Up Days and 45.45% Green Days

The share price of the company has been moving sideways in recent weeks.

About Albireo Pharma, Inc. (ALBO:NASDAQ)

Albireo Pharma Inc is a development-stage pharmaceutical company. It engages in the research and development of the drug reformulation technology. The company is engaged in the development an oral insulin to treat diabetes.